Page last updated: 2024-10-30

labetalol and Blunt Injuries

labetalol has been researched along with Blunt Injuries in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fabian, TC1
Davis, KA1
Gavant, ML1
Croce, MA1
Melton, SM1
Patton, JH1
Haan, CK1
Weiman, DS1
Pate, JW1

Other Studies

1 other study available for labetalol and Blunt Injuries

ArticleYear
Prospective study of blunt aortic injury: helical CT is diagnostic and antihypertensive therapy reduces rupture.
    Annals of surgery, 1998, Volume: 227, Issue:5

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aneurysm, False; Antihypertensive Agents; Aorta; Aortic Ru

1998